ArticleOncology letters2023

Real‑world data indicated that neoadjuvant chemotherapy alone was associated with a higher risk of tumor recurrence in high‑risk breast cancer subgroup patients.

Zhensheng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.